{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:29Z","timestamp":1773285929979,"version":"3.50.1"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/mph.0b013e31816356e3","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T07:08:09Z","timestamp":1207033689000},"page":"301-309","source":"Crossref","is-referenced-by-count":20,"title":["Biologic Characteristics of Mesenchymal Stromal Cells and Their Clinical Applications in Pediatric Patients"],"prefix":"10.1097","volume":"30","author":[{"given":"Iordanis","family":"Pelagiadis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kalmanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210227","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J Embryol Exp Morphol"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1634\/stemcells.22-4-617","article-title":"Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood","volume":"22","author":"Gang","year":"2004","journal-title":"Stem Cells"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1110364","article-title":"Bone marrow stromal cells generate muscle cells and repair muscle degeneration","volume":"309","author":"Dezawa","year":"2005","journal-title":"Science"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.03.086","article-title":"In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells","volume":"330","author":"Hong","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7389","article-title":"Adult bone marrow stromal cells differentiate into neural cells in vitro","volume":"164","author":"Sanchez-Ramos","year":"2000","journal-title":"Exp Neurol"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/01.wnr.0000134846.79002.5c","article-title":"Rapid neural differentiation of human cord blood-derived mesenchymal stem cells","volume":"15","author":"Jeong","year":"2004","journal-title":"Neuroreport"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2141.2003.04284.x","article-title":"Adult bone marrow is a rich source of human Mesenchymal \u201cstem\u201d cells but umbilical cord and mobilized adult blood are not","volume":"121","author":"Wexler","year":"2003","journal-title":"Br J Haematol"},{"key":"R11-8-20210227","first-page":"565","article-title":"The growth characteristics of mesenchymal stem\/progenitor cells in human umbilical cord blood","volume":"11","author":"Cheng","year":"2003","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/ar130","article-title":"Mesenchymal precursor cells in the blood of normal individuals","volume":"2","author":"Zvaifler","year":"2000","journal-title":"Arthritis Res"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexcr.2005.04.029","article-title":"Functional studies of mesenchymal stem cells derived from adult human adipose tissue","volume":"308","author":"Dicker","year":"2005","journal-title":"Exp Cell Res"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2003-06-1967","article-title":"Serum deprivation of human stromal cells with enhanced expression of Oct4 and their embryonic genes","volume":"103","author":"Pochampolly","year":"2004","journal-title":"Blood"},{"key":"R15-8-20210227","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0014-4827(03)00138-1","article-title":"Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2","volume":"287","author":"Bianchi","year":"2003","journal-title":"Exp Cell Res"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcp.20238","article-title":"FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells","volume":"203","author":"Solchaga","year":"2005","journal-title":"J Cell Physiol"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: nature, biology and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"R18-8-20210227","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1634\/stemcells.2004-0331","article-title":"Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1537-2995.2007.01219.x","article-title":"Two steps to functional mesenchymal stromal cells for clinical application","volume":"47","author":"Bartmann","year":"2007","journal-title":"Transfusion"},{"key":"R20-8-20210227","first-page":"3603","article-title":"Bone marrow derived mesenchymal stem cells as vehicles for interferon beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"R23-8-20210227","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1704400","article-title":"Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation","volume":"33","author":"Maitra","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/8756-3282(92)90363-2","article-title":"Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/bbrc.1999.1620","article-title":"The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)","volume":"265","author":"Barry","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","article-title":"Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors","volume":"24","author":"Honczarenko","year":"2006","journal-title":"Stem Cells"},{"key":"R27-8-20210227","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S8756-3282(97)00127-0","article-title":"Monoclonal antibodies reactive with human osteogenic cell surface antigens","volume":"21","author":"Bruder","year":"1997","journal-title":"Bone"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-2478(03)00108-1","article-title":"Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow","volume":"89","author":"De Ugarte","year":"2003","journal-title":"Immunol Lett"},{"key":"R29-8-20210227","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02256058","article-title":"Characterization and functionality of cell surface molecules on human mesenchymal cells","volume":"10","author":"Majumbar","year":"2003","journal-title":"J Biomed Sci"},{"key":"R30-8-20210227","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","article-title":"Cultures of adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice","volume":"92","author":"Pereira","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-8-20210227","doi-asserted-by":"crossref","first-page":"45020","DOI":"10.1074\/jbc.M407050200","article-title":"Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation\u2014defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes","volume":"279","author":"Liu","year":"2004","journal-title":"J Biol Chem"},{"key":"R32-8-20210227","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2741\/1563","article-title":"TGF-beta signaling in chondrocytes","volume":"10","author":"Li","year":"2005","journal-title":"Front Biosci"},{"key":"R33-8-20210227","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","article-title":"Mesenchymal stromal cells: tissue repair and immune modulation","volume":"8","author":"Le Blanc","year":"2006","journal-title":"Cytotherapy"},{"key":"R34-8-20210227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00062752-200111000-00007","article-title":"Cellular therapy: exploiting NK cell alloreactivity in transplantation","volume":"8","author":"Ruggeri","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"R35-8-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"R37-8-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bmt.1704111","article-title":"Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells","volume":"32","author":"Gotherstrom","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R38-8-20210227","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.171.7.3426","article-title":"Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens","volume":"171","author":"Potian","year":"2003","journal-title":"J Immunol"},{"key":"R39-8-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J Biomed Sci"},{"key":"R40-8-20210227","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"R41-8-20210227","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"10","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"R42-8-20210227","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"R43-8-20210227","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"R44-8-20210227","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.4049\/jimmunol.173.7.4352","article-title":"Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma","volume":"173","author":"Akasaki","year":"2004","journal-title":"J Immunol"},{"key":"R45-8-20210227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-3083.2007.01905.x","article-title":"Mesenchymal stem cells stimulate antibody secretion in human B cells","volume":"65","author":"Rasmusson","year":"2007","journal-title":"Scand J Immunol"},{"key":"R46-8-20210227","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbmt.2006.10.016","article-title":"Mesenchymal stromal cells","volume":"13","author":"Horwitz","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R47-8-20210227","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0301-472X(00)00483-5","article-title":"Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection","volume":"28","author":"Li","year":"2000","journal-title":"Exp Hematol"},{"key":"R48-8-20210227","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1023\/B:ABME.0000017545.84833.7c","article-title":"Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs","volume":"32","author":"Crevensten","year":"2004","journal-title":"Ann Biomed Eng"},{"key":"R49-8-20210227","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.1088757","article-title":"Gene targeting in stem cells from individuals with osteogenesis imperfecta","volume":"303","author":"Chamberlain","year":"2004","journal-title":"Science"},{"key":"R50-8-20210227","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jtcvs.2003.07.037","article-title":"Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium","volume":"127","author":"Grinnemo","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R51-8-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(03)28001-3","article-title":"Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases","volume":"228","author":"Sugaya","year":"2003","journal-title":"Int Rev Cytol"},{"key":"R52-8-20210227","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jgm.452","article-title":"Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome","volume":"5","author":"Chapel","year":"2003","journal-title":"J Gene Med"},{"key":"R53-8-20210227","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R54-8-20210227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","article-title":"Mesenchymal stromal cells","volume":"13","author":"Keating","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"R55-8-20210227","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"key":"R56-8-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1525-1594.2001.025003187.x","article-title":"Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering","volume":"25","author":"Fukuda","year":"2001","journal-title":"Artif Organs"},{"key":"R57-8-20210227","first-page":"432","article-title":"Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction","volume":"117","author":"Chen","year":"2004","journal-title":"Chin Med J"},{"key":"R58-8-20210227","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/153537020623100105","article-title":"Mesenchymal stem cells and the treatment of cardiac disease","volume":"231","author":"Minguell","year":"2006","journal-title":"Exp Biol Med"},{"key":"R59-8-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.2002.6519","article-title":"Bone tissue engineering: hope vs. hype","volume":"292","author":"Rose","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R60-8-20210227","first-page":"1920","article-title":"Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects","volume":"29","author":"Adachi","year":"2002","journal-title":"J Rheumatol"},{"key":"R61-8-20210227","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2106\/00004623-199404000-00013","article-title":"Mesenchymal cell-based repair of large, fullthickness defects of articular cartilage","volume":"76","author":"Wakitani","year":"1994","journal-title":"J Bone Joint Surg Am"},{"key":"R62-8-20210227","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jor.1100160403","article-title":"Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair","volume":"16","author":"Young","year":"1998","journal-title":"J Orthop Res"},{"key":"R63-8-20210227","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","article-title":"Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients","volume":"27","author":"Galotto","year":"1999","journal-title":"Exp Hematol"},{"key":"R64-8-20210227","first-page":"207","article-title":"Bone marrow stromal function from patients after bone marrow transplantation","volume":"15","author":"O'Flaherty","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R65-8-20210227","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/archinte.162.14.1558","article-title":"Allogeneic hematopoietic stem cell transplantation. Complications and results","volume":"162","author":"Tabbara","year":"2002","journal-title":"Arch Intern Med"},{"key":"R66-8-20210227","first-page":"14","article-title":"Kinetics of bone marrow repopulation in lethally irradiated rats after transplantation of vascularized bone marrow is syngeneic hind limb","volume":"5","author":"Lukomska","year":"2000","journal-title":"Ann Transplant"},{"key":"R67-8-20210227","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.exphem.2004.08.005","article-title":"Homing efficiency and hematopoietic reconstitution of bone marrow derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro","volume":"32","author":"Jin-Xianga","year":"2004","journal-title":"Exp Hematol"},{"key":"R68-8-20210227","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0301-472X(99)00090-9","article-title":"Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero","volume":"27","author":"Almeida-Porada","year":"1999","journal-title":"Exp Hematol"},{"key":"R69-8-20210227","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0301-472X(03)00042-0","article-title":"Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD\/SCID mice","volume":"31","author":"Angelopoulou","year":"2003","journal-title":"Exp Hematol"},{"key":"R70-8-20210227","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"R71-8-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-Identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R72-8-20210227","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"key":"R73-8-20210227","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MPH.0b013e3180645186","article-title":"Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow","volume":"29","author":"Garc\u00eda-Castro","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"R74-8-20210227","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.exphem.2006.03.007","article-title":"Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation","volume":"34","author":"Pozzi","year":"2006","journal-title":"Exp Hematol"},{"key":"R75-8-20210227","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.leu.2404018","article-title":"Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen","volume":"20","author":"Poloni","year":"2006","journal-title":"Leukemia"},{"key":"R76-8-20210227","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.176.12.7761","article-title":"Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice","volume":"176","author":"Sudres","year":"2006","journal-title":"J Immunol"},{"key":"R77-8-20210227","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","article-title":"Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells","volume":"33","author":"Stenderup","year":"2003","journal-title":"Bone"},{"key":"R78-8-20210227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2121-7-14","article-title":"Aging of mesenchymal stem cell in vitro","volume":"7","author":"Bonad","year":"2006","journal-title":"BMC Cell Biol"},{"key":"R79-8-20210227","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogenic mesenchymal stem cell infusion for treatment of metachromatic leucodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Koc","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R80-8-20210227","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","article-title":"Marrow cell transplantation for infantile hypophosphatasia","volume":"18","author":"Whyte","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R81-8-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"key":"R82-8-20210227","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R83-8-20210227","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"R84-8-20210227","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"key":"R85-8-20210227","first-page":"1229","article-title":"Principles of Bone Biology, 2nd ed","author":"Whyte","year":"2002"},{"key":"R86-8-20210227","first-page":"5313","article-title":"The Metabolic and Molecular Bases of Inherited Disease. 8th ed","author":"Whyte","year":"2001"},{"key":"R87-8-20210227","first-page":"5241","article-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Byers","year":"2001"},{"key":"R88-8-20210227","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/07853890109002055","article-title":"Collagens and collagen-related diseases","volume":"33","author":"Myllyharju","year":"2001","journal-title":"Ann Med"},{"key":"R89-8-20210227","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1073\/pnas.95.3.1142","article-title":"Marrow stromal cells as a source of progenitor cells for non hematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta","volume":"95","author":"Pereira","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R90-8-20210227","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3324\/haematol.11479","article-title":"Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?","volume":"92","author":"Locatelli","year":"2007","journal-title":"Haematologica"},{"key":"R91-8-20210227","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","article-title":"Potential risks of bone marrow cell transplantation into infarcted hearts","volume":"110","author":"Breitbach","year":"2007","journal-title":"Blood"},{"key":"R92-8-20210227","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31816356e3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:02:38Z","timestamp":1620964958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-200804000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31816356e3","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}